Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;7(2):128-134.
doi: 10.15420/aer.2018.23.2.

Premature Ventricular Complex-induced Cardiomyopathy

Affiliations
Review

Premature Ventricular Complex-induced Cardiomyopathy

Jorge G Panizo et al. Arrhythm Electrophysiol Rev. 2018 Jun.

Abstract

Premature ventricular complex-induced cardiomyopathy is a potentially reversible condition in which left ventricular dysfunction is induced by the occurrence of frequent premature ventricular complexes (PVCs). Various cellular and extracellular mechanisms and risk factors for developing cardiomyopathy in this context have been suggested but the exact pathophysiological mechanism remains unclear. The suppression of PVCs is usually indicated in symptomatic patients with frequent PVCs and also those with left ventricular dysfunction. Antiarrhythmic drugs are a useful non-invasive treatment to eliminate PVCs, but the side effect profile, including the risk of pro-arrhythmia, along with suboptimal clinical effectiveness, should be weighed against the usually more effective but not risk-free treatment with catheter ablation. The latter has progressively become first line therapy in many patients with PVC-induced cardiomyopathy and should be particularly considered in specific scenarios.

Keywords: Premature ventricular complex,; antiarrhythmic drug;; arrhythmia;; cardiomyopathy,; heart failure;; non-sustained ventricular tachycardia; outflow tract;; palpitations;; radiofrequency catheter ablation;; ventricular dysfunction,.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Management of Patients Presenting With Frequent Premature Ventricular Complexes
Figure 2:
Figure 2:. Comparison Between Radiofrequency Catheter Ablation Versus Antiarrhythmic Drugs Treatment

References

    1. Gaita F, Giustetto C, Di Donna R et al. Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coil Cardiol. 2001;38:364–70. doi: 10.1016/S0735-1097(01)01403-6. - DOI - PubMed
    1. Kennedy HL, Whitlock JA, Sprague MK et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med. 1985;312:193–7. doi: 10.1056/NEJM198501243120401. - DOI - PubMed
    1. Echt DS, Liebson RR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–8. doi: 10.1056/NEJM199103213241201. - DOI - PubMed
    1. Yarlagadda RK, Iwai S, Stein KM et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation. 2005;112:1092–7. doi: 10.1161/CIRCULATIONAHA.105.546432. - DOI - PubMed
    1. Baman TS, Lange DC, Ilg KJ et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7:865–9. doi: 10.1016/j.hrthm.2010.03.036. - DOI - PubMed

LinkOut - more resources